Research 'leak' hits Genentech

Research ‘leak’ hits Genentech
Genentech’s shares dropped 12.5 per cent after details of the biotechnology company’s research abstracts for next month’s American Society of Clinical Oncology appeared to have been leaked.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog